pubmed-article:9134547 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9134547 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:9134547 | lifeskim:mentions | umls-concept:C0035335 | lld:lifeskim |
pubmed-article:9134547 | lifeskim:mentions | umls-concept:C0677930 | lld:lifeskim |
pubmed-article:9134547 | lifeskim:mentions | umls-concept:C0023866 | lld:lifeskim |
pubmed-article:9134547 | lifeskim:mentions | umls-concept:C1552617 | lld:lifeskim |
pubmed-article:9134547 | lifeskim:mentions | umls-concept:C0282443 | lld:lifeskim |
pubmed-article:9134547 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:9134547 | pubmed:dateCreated | 1997-7-24 | lld:pubmed |
pubmed-article:9134547 | pubmed:abstractText | The aim of this survey was to review the different studies regarding the occurrence of second primary tumours (SPT) among survivors of retinoblastoma. | lld:pubmed |
pubmed-article:9134547 | pubmed:language | eng | lld:pubmed |
pubmed-article:9134547 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9134547 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9134547 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9134547 | pubmed:month | Mar | lld:pubmed |
pubmed-article:9134547 | pubmed:issn | 1381-6810 | lld:pubmed |
pubmed-article:9134547 | pubmed:author | pubmed-author:TanK EKE | lld:pubmed |
pubmed-article:9134547 | pubmed:author | pubmed-author:BouterL MLM | lld:pubmed |
pubmed-article:9134547 | pubmed:author | pubmed-author:MollA CAC | lld:pubmed |
pubmed-article:9134547 | pubmed:author | pubmed-author:ImhofS MSM | lld:pubmed |
pubmed-article:9134547 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9134547 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:9134547 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9134547 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9134547 | pubmed:pagination | 27-34 | lld:pubmed |
pubmed-article:9134547 | pubmed:dateRevised | 2005-11-16 | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:meshHeading | pubmed-meshheading:9134547-... | lld:pubmed |
pubmed-article:9134547 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9134547 | pubmed:articleTitle | Second primary tumors in patients with retinoblastoma. A review of the literature. | lld:pubmed |
pubmed-article:9134547 | pubmed:affiliation | Department of Ophthalmology, Vrije Universiteit, Amsterdam, The Netherlands. | lld:pubmed |
pubmed-article:9134547 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9134547 | pubmed:publicationType | Review | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9134547 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9134547 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9134547 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9134547 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9134547 | lld:pubmed |